Aurobindo Pharma’s unit -- AuroMedics Pharma LLC is recalling 88,080 vials of Tranexamic acid injection, which is used to control or prevent excessive or heavy bleeding during various conditions like dental procedures in patients.
The East Windsor-based drug firm is recalling the affected lot due to the ‘presence of particulate matter: piece of metal found in a vial’. AuroMedics commenced the Class III recall in the US on September 26.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
